The FTC's Targeted Campaign Against Gender-Affirming Care

Introduction

The Federal Trade Commission (FTC) is positioning itself at the forefront of a controversial movement aimed at scrutinizing gender-affirming care for minors. With a series of new hires and investigative actions, the agency appears determined to classify these essential services as consumer protection issues. This shift raises significant concerns about the motivations behind the FTC's actions and their implications for healthcare and transgender rights.

The FTC's Unprecedented Focus on Gender-Affirming Care

Since mid-2025, the FTC has initiated an unusual inquiry into the field of transgender rights healthcare. This campaign, which involves investigations and demands for documentation from various nonprofits, signals a departure from the agency's traditional focus. According to insiders within the agency, the strategy aims to frame gender-affirming treatments as deceptive practices affecting consumers.

“I believe their end goal is to align with a larger ideological agenda against transgender rights,” an anonymous former FTC employee explained. “It feels very strange and unprecedented for a regulatory agency to take such a political stance.”

Document Requests and Investigative Powers

In January 2026, the FTC ramped up its efforts by issuing civil investigative demands (CIDs) to influential organizations that advocate for transgender healthcare, including the American Academy of Pediatrics and the World Professional Association for Transgender Health. These requests serve as a powerful tool for gathering evidence, akin to subpoenas, indicating that the agency is serious about pursuing potential cases against those involved in providing gender-affirming care.

The Leadership Behind the Campaign

The agency's actions have been partly orchestrated by Glenna Goldis, a controversial figure whose background involves a contentious history with advocacy for gender medicine. Goldis's appointment has raised eyebrows given her stated ambitions to challenge the practices of healthcare professionals. Her prior statements indicate a desire to hold practitioners accountable, likening medical interventions for transgender youth to “mutilation.”

Job Postings Indicate a Clear Focus

Recent job openings at the FTC for legal positions highlight the agency's new objective: hiring lawyers to specifically investigate unethical practices related to pediatric gender dysphoria treatment. This targeted recruitment strategy appears designed to enhance the FTC's enforcement capabilities in this contentious area of public health policy.

Complex Implications for Nonprofits

The involvement of the FTC in scrutinizing nonprofit organizations adds another layer of complexity to this issue. A former FTC employee mentioned that targeting nonprofits in their investigations is both unusual and potentially damaging, suggesting a chilling effect on healthcare providers. “If they're scrutinizing nonprofits, what will they do next? Will this prevent practitioners from even offering trans-inclusive care?”

Lawsuits and Responses

Fighting back against the FTC's encroachment can prove both costly and time-consuming. Organizations like the Endocrine Society have already expressed that the financial burden of complying with the FTC's requests could be overwhelming. In one declaration, the chief policy officer at the Endocrine Society noted projected costs exceeding $500,000, highlighting the significant strain on resources.

Cultural and Political Context

Understanding the broader context of these investigations reveals an alarming pattern. The FTC's actions are part of a larger agenda by the Trump administration which has repeatedly targeted transgender rights. In the past, similar initiatives have positioned healthcare providers in opposition to regulatory mandates that they might see as counterproductive to patient care.

Opposition from Within

Internal dissent regarding the FTC's focus has also emerged, as more than 100 staff members voiced concerns that such inquiries could compromise the confidentiality of doctor-patient relationships. This perspective comes amid fears that the FTC is crossing lines previously considered sacrosanct within the medical community.

The Future of Gender-Affirming Care in the U.S.

The FTC's aggressive stance on gender-affirming care raises critical questions about the future of transgender rights in healthcare. As legal scholars and activists alert us, the effects of such regulatory scrutiny may lead to broader implications not just for healthcare providers, but also for the vulnerable populations they serve. The ongoing debates around these issues will likely continue to shape public discourse about gender identity and healthcare access.

Conclusion

In conclusion, the FTC's escalating focus on gender-affirming care reveals a complicated intersection of law, healthcare, and politics. The repercussions of these actions are still unfolding, but they undeniably shape the future landscape of transgender healthcare in the U.S. Stakeholders must remain vigilant and engaged as these developments progress.